# Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures

> **NCT00653978** · PHASE3 · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Cholangiocarcinoma

## Interventions

- **PROCEDURE:** ERCP plus one biliary stent
- **PROCEDURE:** ERCP plus two biliary stents

## Key facts

- **NCT ID:** NCT00653978
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2011-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653978, "Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00653978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*